- ►endojournals.org C Chau-Van, M Gamba, R Salvi, RC Gaillard, … - Endocrinology, 2007 - Endocrine Soc The oral antidiabetic agent metformin acts at least partially via an activation
of AMP-activated kinase (AMPK) in liver and muscle cells. It has appeared
recently that hypothalamic AMPK is a key regulator of feeding in mammals. ... Cited by 22 - Related articles - BL Direct - All 2 versions
B Staels - Current Medical Research and Opinion®, 2006 - informahealthcare.com Institut Pasteur de Lille – Département d'Athérosclérose, Inserm U545 and
Université de Lille 2, Lille, France ... Address for correspondence: Bart
Staels, Institut Pasteur de Lille, Département d'Athérosclérose, Lille, ... Cited by 15 - Related articles - All 6 versions
H Shimizu, S Oh-i, S Okada, M Mori - ENDOCRINE JOURNAL-TOKYO-, 2007 - leptinresearch.org LEPTIN was discovered in 1994 in the genetically obese (ob/ob) mouse [1]. Leptin
is one of the most important and powerful anorexigenic factors related to the
brain-adipose axis [2]. It is synthesized in and released from adipose ... Cited by 11 - Related articles - BL Direct - All 6 versions
YW Kim, SY Park, JY Kim, JY Huh, WS Jeon, … - Journal of andrology, 2007 - Am Soc Andrology Obesity is a well-known risk factor for erectile dysfunction, which is
associated with reduced penile nitric oxide synthase (NOS) expression. Recently
it was reported that metformin activates AMP-activated protein kinase ... Cited by 11 - Related articles - BL Direct - All 7 versions
- ►endojournals.org ER Ropelle, JR Pauli, KG Zecchin, M Ueno, … - Endocrinology, 2007 - Endocrine Soc The pathogenesis of cancer anorexia is multifactorial and associated with
disturbances of the central physiological mechanisms controlling food intake.
However, the neurochemical mechanisms responsible for cancer-induced ... Cited by 6 - Related articles - BL Direct - All 3 versions
T Baptista, I Sandia, A Lacruz, N Rangel, S … - International clinical psychopharmacology, 2007 - journals.lww.com Page 1. Original article 69 Insulin counter-regulatory factors, fibrinogen and
C-reactive protein during olanzapine administration: effects of the ... Cited by 6 - Related articles - BL Direct - All 5 versions
T Tsilchorozidou, RL Batterham, GS Conway - Clinical Endocrinology, 2008 - interscience.wiley.com Objective The beneficial effects of metformin in patients with type 2 diabetes
mellitus (T2DM) and polycystic ovarian syndrome (PCOS) are thought to be in part
due to weight reduction. However, the mechanisms by which metformin causes ... Cited by 6 - Related articles - All 4 versions
I Kusaka, S Nagasaka, H Horie, S Ishibashi - Diabetes Obes Metab, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 4 - Related articles - All 2 versions
MH Mooney, S Fogarty, C Stevenson, AM … - British journal of pharmacology, 2008 - pubmedcentral.nih.gov Key results: Galegine administered in the diet reduced body weight in mice.
Pair-feeding indicated that at least part of this effect was independent of
reduced food intake. In 3T3-L1 adipocytes and L6 myotubes, galegine (50 ... Cited by 3 - Related articles - BL Direct - All 5 versions
